https://scholars.lib.ntu.edu.tw/handle/123456789/560051
標題: | Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: A retrospective analysis of a single hospital's experience | 作者: | Hsu K.H. NAI-KUAN CHOU MENG-KUN TSAI NAI-HSIN CHI YIH-SHARNG CHEN HSI-YU YU Wang C.H. Ko W.J. Tsao C.I. PO-HUANG LEE SHOEI-SHEN WANG |
公開日期: | 2010 | 卷: | 42 | 期: | 3 | 起(迄)頁: | 934-937 | 來源出版物: | Transplantation Proceedings | 摘要: | Simultaneous heart and kidney transplantation (SHKT) has become an accepted therapeutic option for patients with end-stage heart failure associated with end-stage renal disease. The immunosuppressive therapy is usually based upon a heart transplantation protocol using a calcineurin inhibitor (CNI). Sirolimus (SRL) is a potent nonnephrotoxic immunosuppressant with antiproliferative activity in nonimmune cells. Its use has recently been reported to show less nephrotoxicity among both heart and kidney transplants. However, the data for the SHKT are limited. We retrospectively examined the causes of 5 patients who received combined SRL-CNI immunosuppressive therapy with reduced CNI doses from 2003 to 2009. There was no mortality during follow-up. Two of the 3 patients who received a conversion regimen recovered renal function. One who suffered severe proteinuria after transplantation proceeded to hemodialysis at 3 years after conversion. Both of the patients who received the combined regimen de novo remained stable regarding their renal function. Cardiac function was stable in these patients; there was neither allograft rejection nor allograft coronary vasculopathy. We observed that patients without dyslipidemia or hyperuricemia before SHKT were less likely to develop these disorders under the combined regimen. Early medical intervention after close follow-up of lipid and uric acid values by dose adjustments resulted in a stable status of our patients. ? 2010 Elsevier Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955499931&doi=10.1016%2fj.transproceed.2010.03.009&partnerID=40&md5=36c90077d51f673c18259923a13bbea1 https://scholars.lib.ntu.edu.tw/handle/123456789/560051 |
ISSN: | 0041-1345 | DOI: | 10.1016/j.transproceed.2010.03.009 | SDG/關鍵字: | calcineurin; cyclosporin; drug derivative; immunosuppressive agent; lymphocyte antibody; mycophenolic acid; mycophenolic acid 2 morpholinoethyl ester; prednisolone; rapamycin; tacrolimus; adolescent; adult; article; chronic kidney failure; drug antagonism; drug combination; female; heart failure; heart transplantation; histocompatibility test; human; immunology; kidney transplantation; male; middle aged; retrospective study; Adolescent; Antilymphocyte Serum; Calcineurin; Cyclosporine; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Sirolimus; Tacrolimus; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。